| 1 | du cancer de la | | | | | | | 2 | 0.37% |
| 2 | cancer de la prostate | | | | | | | 2 | 0.37% |
| 3 | de chef de file | | | | | | | 2 | 0.37% |
| 4 | isologic innovative radiopharmaceuticals logo | | | | | | | 2 | 0.37% |
| 5 | skip to content appeleznous | | | | | | | 1 | 0.18% |
| 6 | viceprÉsidente des opÉrations jeanne | | | | | | | 1 | 0.18% |
| 7 | et dÉveloppement de nouveaux | | | | | | | 1 | 0.18% |
| 8 | directeur principal de cmcqualitÉ | | | | | | | 1 | 0.18% |
| 9 | martin directeur principal de | | | | | | | 1 | 0.18% |
| 10 | stephane martin directeur principal | | | | | | | 1 | 0.18% |
| 11 | humaines stephane martin directeur | | | | | | | 1 | 0.18% |
| 12 | ressources humaines stephane martin | | | | | | | 1 | 0.18% |
| 13 | opÉrations jeanne yaourtsakis viceprÉsidente | | | | | | | 1 | 0.18% |
| 14 | des opÉrations jeanne yaourtsakis | | | | | | | 1 | 0.18% |
| 15 | viceprÉsident dÉveloppement des affaires | | | | | | | 1 | 0.18% |
| 16 | des affaires annette proulx | | | | | | | 1 | 0.18% |
| 17 | dÉveloppement des affaires annette | | | | | | | 1 | 0.18% |
| 18 | de nouveaux produits vasa | | | | | | | 1 | 0.18% |
| 19 | maiorino viceprÉsident dÉveloppement des | | | | | | | 1 | 0.18% |
| 20 | ventes et marketing frank | | | | | | | 1 | 0.18% |
| 21 | viceprÉsidente ventes et marketing | | | | | | | 1 | 0.18% |
| 22 | henault viceprÉsidente ventes et | | | | | | | 1 | 0.18% |
| 23 | christine henault viceprÉsidente ventes | | | | | | | 1 | 0.18% |
| 24 | finances christine henault viceprÉsidente | | | | | | | 1 | 0.18% |
| 25 | direction david paradis viceprÉsident | | | | | | | 1 | 0.18% |
| 26 | de direction david paradis | | | | | | | 1 | 0.18% |
| 27 | dÉveloppement de nouveaux produits | | | | | | | 1 | 0.18% |
| 28 | nouveaux produits vasa sindolic | | | | | | | 1 | 0.18% |
| 29 | patients Équipe de direction | | | | | | | 1 | 0.18% |
| 30 | isotope production facility in | | | | | | | 1 | 0.18% |
| 31 | is investing 299 million | | | | | | | 1 | 0.18% |
| 32 | radiopharmaceuticals is investing 299 | | | | | | | 1 | 0.18% |
| 33 | innovative radiopharmaceuticals is investing | | | | | | | 1 | 0.18% |
| 34 | isologic innovative radiopharmaceuticals is | | | | | | | 1 | 0.18% |
| 35 | – isologic innovative radiopharmaceuticals | | | | | | | 1 | 0.18% |
| 36 | montreal june 4 2024 | | | | | | | 1 | 0.18% |
| 37 | quebec montreal june 4 | | | | | | | 1 | 0.18% |
| 38 | in quebec montreal june | | | | | | | 1 | 0.18% |
| 39 | facility in quebec montreal | | | | | | | 1 | 0.18% |
| 40 | production facility in quebec | | | | | | | 1 | 0.18% |